Author:
Kreutz Reinhold,Algharably Engi Abd El-Hady
Publisher
Springer International Publishing
Reference22 articles.
1. Algharably E, Kreutz R (2019) In: Mancia G, Grassi G, Tsioufis K, Dominiczak A, Rosei EA (eds) Manual of hypertension of the European Society of hypertension, 3rd edn. CRC Press, London
2. Arendse LB, Danser AHJ, Poglitsch M, Touyz RM, Burnett JC Jr, Llorens-Cortes C, Ehlers MR, Sturrock ED (2019) Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev 71(4):539–570. https://doi.org/10.1124/pr.118.017129
3. Ayers K, Byrne LM, DeMatteo A, Brown NJ (2012) Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension 59(4):893–898. https://doi.org/10.1161/hypertensionaha.111.189589
4. Baker JG (2005) The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144(3):317–322. https://doi.org/10.1038/sj.bjp.0706048
5. Benowitz N (2015) Antihypertensive agents. In: Katzung BG, Trevor AJ (eds) Basic & clinical pharmacology, 13th edn. McGraw-Hill education, New York, pp 169–190
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献